245 related articles for article (PubMed ID: 33759443)
1. Metformin improves survival in patients with concurrent diabetes and small cell lung cancer: a meta-analysis.
Fan H; Bai S; Guan X; Ma W; Fu Y; Zhang X; Deng L; Tian J
Minerva Endocrinol (Torino); 2023 Jun; 48(2):214-221. PubMed ID: 33759443
[TBL] [Abstract][Full Text] [Related]
2. Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus.
Lu H; Xie F; Huang Z; Qin J; Han N; Mao W
Adv Clin Exp Med; 2018 Sep; 27(9):1195-1199. PubMed ID: 30016011
[TBL] [Abstract][Full Text] [Related]
3. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
Zeng S; Gan HX; Xu JX; Liu JY
Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of small cell lung cancer patients with diabetes treated with metformin.
Xu T; Liang G; Yang L; Zhang F
Clin Transl Oncol; 2015 Oct; 17(10):819-24. PubMed ID: 26063645
[TBL] [Abstract][Full Text] [Related]
5. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
6. Metformin use improves the survival of diabetic combined small-cell lung cancer patients.
Kong F; Gao F; Liu H; Chen L; Zheng R; Yu J; Li X; Liu G; Jia Y
Tumour Biol; 2015 Sep; 36(10):8101-6. PubMed ID: 25983003
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of metformin for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Zhang J; Wu J; He Q; Liang W; He J
Transl Lung Cancer Res; 2018 Jun; 7(3):389-396. PubMed ID: 30050776
[TBL] [Abstract][Full Text] [Related]
9. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
[TBL] [Abstract][Full Text] [Related]
10. Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum.
Wen-Xiu X; Xiao-Wei Z; Hai-Ying D; Ying-Hui T; Si-Si K; Xiao-Fang Z; Huang P
Medicine (Baltimore); 2018 Dec; 97(51):e13652. PubMed ID: 30572481
[TBL] [Abstract][Full Text] [Related]
11. The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Jacobi O; Landman Y; Reinhorn D; Icht O; Sternschuss M; Rotem O; Finkel I; Allen AM; Dudnik E; Goldstein DA; Zer A
Oncology; 2021; 99(9):555-561. PubMed ID: 34247166
[TBL] [Abstract][Full Text] [Related]
12. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies.
Zhu L; Cao H; Zhang T; Shen H; Dong W; Wang L; Du J
Medicine (Baltimore); 2016 Apr; 95(17):e3528. PubMed ID: 27124062
[TBL] [Abstract][Full Text] [Related]
15. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract][Full Text] [Related]
16. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.
Yin M; Zhou J; Gorak EJ; Quddus F
Oncologist; 2013; 18(12):1248-55. PubMed ID: 24258613
[TBL] [Abstract][Full Text] [Related]
17. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
18. The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients.
Tsou YA; Chang WD; Lu JJ; Wu TF; Chen HL; Chen CM; Tsai MH
BMC Cancer; 2019 Aug; 19(1):862. PubMed ID: 31470817
[TBL] [Abstract][Full Text] [Related]
19. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.
Arrieta O; Varela-Santoyo E; Soto-Perez-de-Celis E; Sánchez-Reyes R; De la Torre-Vallejo M; Muñiz-Hernández S; Cardona AF
BMC Cancer; 2016 Aug; 16():633. PubMed ID: 27519177
[TBL] [Abstract][Full Text] [Related]
20. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
